Sharmi Naha

804 citations
10 papers · 201 indexed · h-index 7
Topics
Antibiotic Resistance in Bacteria (10 papers)Antibiotics Pharmacokinetics and Efficacy (5 papers)Enterobacteriaceae and Cronobacter Research (3 papers)

In The Last Decade

Sharmi Naha

9 papers receiving 198 citations

Peers

Sharmi Naha
Comparison fields: 5 of 40
  • Molecular Medicine 170
  • Pharmacology 55
  • Endocrinology 52
  • Epidemiology 51
  • Molecular Biology 42
Replace Sergio Esparza-Ahumada with:
Sergio Esparza-Ahumada Mexico
Erika Kocsis Hungary
Priscila Lamb Wink Brazil
Ngoc Thi Bich Hoang Vietnam
Efstratios Mainas Greece
Cindy Wing‐Sze Tse China
Silke Nickel Germany
Lim Jones United Kingdom
Zhusheng Guo China
Yannick Charretier Switzerland
Sharmi Naha relative to Sergio Esparza-Ahumada Mexico Sergio Esparza-Ahumada's profile →
Citations per field
00.5×3.2×
Sergio Esparza-Ahumada · 1×
Citations per year

Countries citing papers authored by Sharmi Naha

Since Specialization
Citations

This map shows the geographic impact of Sharmi Naha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharmi Naha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharmi Naha more than expected).

Fields of papers citing papers by Sharmi Naha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharmi Naha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharmi Naha. The network helps show where Sharmi Naha may publish in the future.

Co-authorship network of co-authors of Sharmi Naha

This figure shows the co-authorship network connecting the top 25 collaborators of Sharmi Naha. A scholar is included among the top collaborators of Sharmi Naha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharmi Naha. Sharmi Naha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 0
2 26
3 3
4 4
5 16
6 8
7 41
8 43
9 29
10 31

About Sharmi Naha

Sharmi Naha is a scholar working on Molecular Medicine, Endocrinology and Pharmacology, having authored 10 papers that have together received 201 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Enterobacteriaceae and Cronobacter Research (3 papers). The work is most often cited by research in Molecular Medicine (170 citations), Applied Microbiology and Biotechnology (26 citations) and Endocrinology (52 citations). Sharmi Naha has collaborated with scholars based in India, United Kingdom and Portugal. Frequent co-authors include Sulagna Basu, Shanta Dutta, Subhankar Mukherjee, Kirsty Sands, Suchandra Mukherjee, Pinaki Chattopadhyay, Chayan Roy, Bijan Saha, Moidu Jameela Rameez and Timothy R. Walsh. Their work appears in journals such as Frontiers in Microbiology, Journal of Antimicrobial Chemotherapy and International Journal of Antimicrobial Agents.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026